Direkt zum Inhalt
Merck

MBD0021

Sigma-Aldrich

Inactivated Bacillus subtilis

Suitable for PCR, sequencing and NGS, >10^8 bacteria/ml

Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise


About This Item

UNSPSC-Code:
43211915

Qualitätsniveau

Form

powder

Konzentration

>10^8 bacteria/ml

Methode(n)

DNA extraction: suitable
DNA sequencing: suitable
PCR: suitable

Versandbedingung

dry ice

Lagertemp.

−20°C

Allgemeine Beschreibung

Standardization of sample analysis is currently needed in microbiome genomics research workflow. Lack of standardization can lead to biases and errors in common processes during sample preparation and analysis such as sample amplification, sequencing and bioinformatics analyses.1 Inactivated Bacillus subtilis (B. subtilis) can serve as standard for benchmarking the performance along the workflow of microbiomics or meta-genomics analyses and as a tool to increase reproducibility and allow comparison of results obtained by different labs.B. subtilis is a gram positive, aerobic bacterium, rod-shaped, endospore-forming, catalase-positive. It is traditionally considered as a soil microorganism.2 Bacillus subtilis is genetically well characterized and serves as a model organism for important gram-positive pathogens such as Bacillus anthracis, Staphylococcus aureus etc.3 B. subtilis possess an extreme adaptation ability to various environmental stress conditions by modifying its motility 4, uptake of exogenous DNA 5, biofilm formation and sporulation6.Recent studies have identified and characterized B. subtilis isolates from human gastrointestinal track suggesting B.subtilis as a gut commensal.7 Moreover, B. subtilis presence in the gut was found to correlate with probiotic effects such as anti-diarrhea effect, anti-microbial effect, immune-stimulatory effect, competition with pathogens, normal flora growth stimulation and prevention of intestinal inflammation.8,9. B. subtilis beneficial effect on gut inflammation may also suggest it as potential probiotic treatment for inflammatory bowel diseases (IBD), including Crohn’s and ulcerative colitis.10 In addition, it was demonstrated that a peptide produced by B. subtilis possess antiviral effect against influenza virus.11

Read here how to use our standards to ensure data integrity for your microbiome research.

Anwendung

Inactivated bacteria are provided at >10^8 bacteria/vial as lyophilized powder. It is recommended to avoid freeze thaw cycles of this product.

Rekonstituierung

It is recommended to dissolve the lyophilized inactivated bacteria in water (Sigma Cat# W4502 ) supplemented with at least 10% glycerol (Sigma Cat# G5516). Once dissolved it is recommended to aliquot immediately and store at -20°C for up to 1 month and avoid freeze thaw cycles.

Lagerklassenschlüssel

11 - Combustible Solids

WGK

WGK 3


Analysenzertifikate (COA)

Suchen Sie nach Analysenzertifikate (COA), indem Sie die Lot-/Chargennummer des Produkts eingeben. Lot- und Chargennummern sind auf dem Produktetikett hinter den Wörtern ‘Lot’ oder ‘Batch’ (Lot oder Charge) zu finden.

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung.